A 42-year-old woman with community-acquired pneumonia is admitted to the ICU with sepsis. She has received 2 L of crystalloid fluid bolus and is on noradrenaline 0.1 mcg/kg/min. Current vitals: BP 88/54 mmHg, HR 128/min, RR 28/min, lactate 4.8 mmol/L (down from 6.2 mmol/L 2 hours ago). Urine output is 0.3 mL/kg/hr. What is the most appropriate next step in management?

Explanation

## Septic Shock: Vasopressor Titration and Reassessment ### Clinical Context Analysis **Key Point:** This patient shows signs of inadequate tissue perfusion despite initial fluid resuscitation: - Persistent hypotension (BP 88/54 mmHg, MAP ~65 mmHg) - Elevated lactate (4.8 mmol/L) — though trending down, still significantly elevated - Oliguria (0.3 mL/kg/hr; target ≥0.5 mL/kg/hr) - Persistent tachycardia and tachypnea The lactate is *improving* (from 6.2 to 4.8), indicating some response to initial resuscitation, but the patient remains hypotensive and underperfused. ### Vasopressor Escalation Strategy **High-Yield:** In septic shock, the Surviving Sepsis Campaign algorithm mandates: 1. **Initial fluid bolus:** 30 mL/kg crystalloid (completed) 2. **First-line vasopressor:** Noradrenaline to target MAP ≥65 mmHg (patient is on it but underdosed) 3. **Titration:** Increase noradrenaline incrementally until MAP goal is achieved 4. **Second-line vasopressor:** Add vasopressin (0.03–0.04 U/min fixed) or epinephrine only if noradrenaline inadequate **Clinical Pearl:** A MAP of 65 mmHg is the *minimum* target; many clinicians target 75–80 mmHg in septic shock, especially with persistent hyperlactataemia. The patient's current noradrenaline dose (0.1 mcg/kg/min) is suboptimal for her BP. ### Vasopressor Comparison Table | Vasopressor | First-line? | Mechanism | Target | Notes | |---|---|---|---|---| | Noradrenaline | **Yes** | α + β effect | MAP ≥65 mmHg | Preferred; titrate first | | Vasopressin | No (add-on) | V1 receptor | Fixed 0.03–0.04 U/min | Add if noradrenaline inadequate | | Epinephrine | No (add-on) | α + β (high-dose) | Reserved for refractory shock | Risk of tachycardia, hyperglycemia | | Dobutamine | No | β1 > β2 | Not recommended in septic shock | Causes vasodilation; worsens hypotension | ### Management Algorithm ```mermaid flowchart TD A[Septic shock on noradrenaline]:::outcome --> B{MAP ≥65 mmHg?}:::decision B -->|No| C[Increase noradrenaline incrementally]:::action B -->|Yes| D{Lactate normalizing?}:::decision C --> E[Reassess BP, lactate, urine output]:::action D -->|Yes| F[Continue current dose, monitor]:::action D -->|No| G{Noradrenaline at max tolerated dose?}:::decision G -->|Yes| H[Add vasopressin or epinephrine]:::action G -->|No| I[Continue escalating noradrenaline]:::action H --> J[Consider hydrocortisone if refractory]:::action ``` **Mnemonic:** **MAPS** = Manage Antibiotics, Pressors (escalate), Source control, Steroids (if refractory) ### Why Not a Second Fluid Bolus? **Warning:** The patient has already received 2 L of crystalloid (likely ~30 mL/kg). Reassessment shows: - Improving lactate (good sign of some perfusion recovery) - Oliguria (0.3 mL/kg/hr) — suggests either inadequate perfusion OR fluid overload with acute kidney injury - Normal CVP/PCWP data not provided, but persistent hypotension on vasopressor suggests *vasoplegia*, not hypovolemia Further fluid boluses risk pulmonary edema and worsening outcomes in vasoplegia-dominant septic shock. [cite:Harrison 21e Ch 297; Surviving Sepsis Campaign 2021]